{"id":6368,"date":"2022-11-26T02:37:39","date_gmt":"2022-11-26T07:37:39","guid":{"rendered":"https:\/\/pasinex.com\/?page_id=6368"},"modified":"2022-12-12T10:20:32","modified_gmt":"2022-12-12T15:20:32","slug":"finanzberichte","status":"publish","type":"page","link":"https:\/\/pasinex.com\/de\/investors-hub\/finanzberichte\/","title":{"rendered":"Finanzberichte"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8220;1&#8243; disabled_on=&#8220;on|on|off&#8220; admin_label=&#8220;Section&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;0px||0px||true|false&#8220; saved_tabs=&#8220;all&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;13px||13px||true|false&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_menu menu_id=&#8220;40&#8243; active_link_color=&#8220;#1D6CB6&#8243; module_id=&#8220;top-header-menu&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; menu_font=&#8220;|700|||||||&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_menu][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; fullwidth=&#8220;on&#8220; _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_fullwidth_header title=&#8220;Finanzberichte&#8220; _builder_version=&#8220;4.19.1&#8243; title_font=&#8220;|700||on|||||&#8220; title_font_size=&#8220;50px&#8220; background_enable_color=&#8220;off&#8220; background_image=&#8220;https:\/\/pasinex.com\/wp-content\/uploads\/2018\/06\/mining-company-in-turkey.jpg&#8220; custom_css_title=&#8220;margin-top:100px;&#8220; global_colors_info=&#8220;{}&#8220; button_one_text_size__hover_enabled=&#8220;off&#8220; button_two_text_size__hover_enabled=&#8220;off&#8220; button_one_text_color__hover_enabled=&#8220;off&#8220; button_two_text_color__hover_enabled=&#8220;off&#8220; button_one_border_width__hover_enabled=&#8220;off&#8220; button_two_border_width__hover_enabled=&#8220;off&#8220; button_one_border_color__hover_enabled=&#8220;off&#8220; button_two_border_color__hover_enabled=&#8220;off&#8220; button_one_border_radius__hover_enabled=&#8220;off&#8220; button_two_border_radius__hover_enabled=&#8220;off&#8220; button_one_letter_spacing__hover_enabled=&#8220;off&#8220; button_two_letter_spacing__hover_enabled=&#8220;off&#8220; button_one_bg_color__hover_enabled=&#8220;off&#8220; button_two_bg_color__hover_enabled=&#8220;off&#8220;][\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; saved_tabs=&#8220;all&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2022 Financial Reports<\/h2>\n<p><a href=\"\/news\/2022\/FS-Q3-2022.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2022 Finanzberichte<\/a><br \/>\n<a href=\"\/news\/2022\/MDA-Q3-2022.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2022 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a><\/p>\n<p><a href=\"\/news\/2022\/Pasinex-FS-June-30-2022.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2022 Finanzberichte<\/a><br \/>\n<a href=\"\/news\/2022\/MDA-Q2-2022.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2022 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a><\/p>\n<p><a href=\"\/news\/2022\/Pasinex-FS-March-31-2022.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2022 Finanzberichte<\/a><br \/>\n<a href=\"\/news\/2022\/MDA-Q1-2022.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2022 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; saved_tabs=&#8220;all&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2021 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/news\/2022\/PSE-FS-December-31-2021.pdf\" target=\"_blank\" rel=\"noopener\">Final Year ended December 2021<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/news\/2022\/PSE-2021-MDA.pdf\" target=\"_blank\" rel=\"noopener\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A) for the Year Ended December 31, 2021<\/a><\/p>\n<p><a href=\"\/news\/2021\/Pasinex-FS-Q3-2021.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2021 Finanzberichte<\/a><br \/>\n<a href=\"\/news\/2021\/Pasinex-MDA-Q3-2021.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2021 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a><\/p>\n<p><a href=\"\/news\/2021\/Pasinex-FS-June-30-2021.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2021 Finanzberichte<\/a><br \/>\n<a href=\"\/news\/2021\/MDA-Q2-2021.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2021 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a><\/p>\n<p><a href=\"\/news\/2021\/Pasinex-FS-March-31-2021.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2021 Finanzberichte<\/a><br \/>\n<a href=\"\/news\/2021\/MDA-Q1-2021.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2021 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2020 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/news\/2021\/PSE-FS-December-31-2020.pdf\" target=\"_blank\" rel=\"noopener\">Final Year ended December 2020<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/news\/2021\/PSE-2020-MDA.pdf\" target=\"_blank\" rel=\"noopener\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A) for the Year Ended December 31, 2020<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/news\/2020\/PSE-Q3-2020-FS.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2020 Finanzberichte<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/news\/2020\/MDA-Q3-2020.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Quarter 3 September 2020 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/news\/2020\/Pasinex-FS-June-30-2020.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2020 Finanzberichte<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/news\/2020\/MDA-Q2-2020.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2020 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/news\/2020\/Pasinex-FS-March-31-2020.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2020 Finanzberichte<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/news\/2020\/MDA-Q1-2020.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Quarter 1 March 2020 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2019 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/news\/2020\/Pasinex-FS-December-31-2019-with-Audit.pdf\" target=\"_blank\" rel=\"noopener\">Final Year ended December 2019<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/news\/2020\/PSE-2019-MDA.pdf\" target=\"_blank\" rel=\"noopener\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A) for the Year Ended December 31, 2019<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/news\/2019\/Pasinex-FS-September-30-2019.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2019 Financial Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/news\/2019\/MDA-Q3-2019.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2019 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/news\/2019\/Pasinex-FS-June-30-2019.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2019 Financial Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/news\/2019\/MDA-Q2-2019.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2019 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/news\/2019\/MDA-Q1-2019.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2019 Financial Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/news\/2019\/Pasinex-FS-March-31-2019.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2019 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2018 Financial Reports<\/h2>\n<p><a href=\"\/news\/2019\/Pasinex-FS-December-31-2018.pdf\">Final Year ended December 2018<\/a><br \/>\n<a href=\"\/news\/2019\/Pasinex-MDA-December-31-2018.pdf\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) for the Year Ended December 31, 2018<\/a><\/p>\n<p><a href=\"\/news\/2018\/Pasinex-FS-Q3-2018.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2018 Financial Statement<\/a><br \/>\n<a href=\"\/news\/2018\/Pasinex-MDA-Q3-2018.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2018 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"\/news\/2018\/Pasinex-FS-Q2-2018.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2018 Financial Statement<\/a><br \/>\n<a href=\"\/news\/2018\/Pasinex-MDA-Q2-2018.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2018 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"http:\/\/go.pardot.com\/l\/494351\/2018-05-24\/6cslcc\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2018 Financial Statement<\/a><br \/>\n<a href=\"http:\/\/go.pardot.com\/l\/494351\/2018-05-24\/6cslg5\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2018 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2017 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-FS-December-31-2017.pdf\">Final Year ended December 2017<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-MDA-December-31-2017.pdf\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) for the Year Ended December 31, 2017<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q2-FS-September-30-2017.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2017 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-MDA-September-30-2017.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2017 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q2-FS-June-30-2017.pdf.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2017 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q2-MDA-June-30-2017.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2017 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q1-FS-March-31-2017.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2017 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q1-MDA-Mar-31-2017.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2017 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2016 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q4-FS-December-31-2016.pdf\" target=\"_blank\" rel=\"noopener\">Final Year ended December 2016<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q4-MDA-Dec-31-2016.pdf\" target=\"_blank\" rel=\"noopener\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) for the Year Ended December 31, 2016<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-FS-September-30-2016.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2016 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/MDA-Quarterly-Highlights-Q3-2016.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2016 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/PSE-Q2FS-Jun30-2016.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2016 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/PSE-Q2MDA-Jun30-2016.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2016 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q1-FS-March-31-2016.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2016 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q1-MDA-Mar-31-2016.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2016 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2015 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q4-FS-December-31-2015.pdf\" target=\"_blank\" rel=\"noopener\">Final Year ended December 2015<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q4-MDA-Dec-31-2015.pdf\" target=\"_blank\" rel=\"noopener\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) for the Year Ended December 31, 2015<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q3-FS-September-30-2015.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2015 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q3-MDA-Sep-30-2015.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 September 2015 Management Discussion and Analysis<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q2-FS-June-30-2015.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2015 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q2-MDA-June-30-2015.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 June 2015 Management Discussion and Analysis<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q1-FS-March-31-2015.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2015 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q1-MDA-Mar-31-2015.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 March 2015 Management Discussion and Analysis<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2014 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-FS-December-31-2014.pdf\">Final Year ended December 2014<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q4-MDA-Dec-31-2014.pdf\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) for the Year Ended December 31, 2014<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-FS-September-30-2014.pdf\">Quarter 3 September 2014 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q3-MDA-Sep-30-2014.pdf\">Quarter 3 September 2014 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/01\/Pasinex-FS-June-30-2014-FINAL.pdf\">Quarter 2 June 2014 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/01\/Pasinex-Q2-MDA-Jun-30-2014-FINAL.pdf\">Quarter 2 June 2014 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/01\/Pasinex-FS-March-31-2014-FINAL.pdf\">Quarter 1 March 2014 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/01\/Pasinex-Q1-MDA-Mar-31-2014-FINAL.pdf\">Quarter 1 March 2014 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2013 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/01\/Pasinex-FS-December-31-2013-FINAL.pdf\">Final Year ended December 2013<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/01\/Pasinex-Q4-MDA-Dec-31-2013-FINAL.pdf\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) for the Year Ended December 31, 2013<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q3-FS-September-30-2013.pdf\">Quarter 3 September 2013 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q3-MDA-Sepember-30-2013.pdf\">Quarter 3 September 2013 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q2-FS-June-30-2013.pdf\">Quarter 2 June 2013 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q2-MDA-June-30-2013.pdf\">Quarter 2 June 2013 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-FS-Mar-31-2013-FINAL.pdf\">Quarter 1 March 2013 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q1-MDA-Mar-31-2013-FINAL.pdf\">Quarter 1 March 2013 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2012 Financial Reports *<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-FS-IFRS-Mar-31-2012-FINAL.pdf\" target=\"_blank\" rel=\"noopener\">Final Year ended March 2012<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/PSE-MDA-Mar-31-2012-FINAL.pdf\" target=\"_blank\" rel=\"noopener\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) for the Year Ended March 31, 2012<\/a><\/p>\n<p><a title=\"Quarter 3 December 2012 Statement\" href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-FS-Dec-31-2012.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 December 2012 Statement<\/a><br \/>\n<a title=\"Quarter 3 December 202 Management Discussions and Analysis\" href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q3-MDA-Dec-31-2012.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 December 2012 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a title=\"Called Quarter 2 September 2012 Statement\" href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q2-FS-Sept-30-2012-FINAL.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 September 2012 Statement<\/a><br \/>\n<a title=\"Quarter 2 September 2012 Management Discussion and Analysis\" href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/Pasinex-Q2-MDA-Sep-30-2012-FINAL.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 September 2012 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/08\/Pasinex-Q1-FS-June-30-2012.pdf\">Quarter 1 June 2012 Statement<\/a><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/08\/Pasinex-Q1-MDA-Jun-30-2012.pdf\"><br \/>\nQuarter 1 June 2012 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2011 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TD-FS-Q4-Mar-2010-FINAL.pdf\" target=\"_blank\" rel=\"noopener\">Final Year ended March 2011 <\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TD-MDA-Mar-31-2010-final.pdf\" target=\"_blank\" rel=\"noopener\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) for the Year Ended March 31 2011<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TD-FS-Q3-Dec-2010-Final-BCSC-update.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 2011 ended December 2010<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TD-MDA-Dec-31-2010-Final-BCSC-update.pdf\" target=\"_blank\" rel=\"noopener\"> Quarter 3 2011 ended December 2010 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TDNQ2093010financial.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 2011 ended September 2010<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TDNQ2093010mda.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 2011 ended September 2010 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TDNQ1063010financials.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 2011 ended June 2010 Statement<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TDNQ1063010mda.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 2011 ended June 2010 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A)<\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.1&#8243; link_text_color=&#8220;#000000&#8243; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>2010 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TD-MDA-Mar-31-2010-final.pdf\" target=\"_blank\" rel=\"noopener\">Final Year ended March 2010<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TD-FS-Q4-Mar-2010-FINAL.pdf\" target=\"_blank\" rel=\"noopener\">Final Year ended March 2010 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) <\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TDNQ4033110FINANCIALS.pdf\" target=\"_blank\" rel=\"noopener\">Yearly results March 2010<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TDNQ4033110MDA.pdf\" target=\"_blank\" rel=\"noopener\">Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) for the Year Ended March 31 2010<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/2010Q3FS.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 December 2010<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/2010Q3MDA.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 December 2010 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) <\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/2010Q2FS.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 September 2010<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/2010Q2mda.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 2 September 2010 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) <\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/2010-Q1-FS.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 June 2010<\/a><br \/>\n<a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/2010-Q1-MDA.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 June 2010 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&#038;A) <\/a>[\/et_pb_text][et_pb_text admin_label=&#8220;Share Capitalization&#8220; module_class=&#8220;black&#8220; _builder_version=&#8220;4.19.2&#8243; link_text_color=&#8220;#000000&#8243; hover_enabled=&#8220;0&#8243; global_colors_info=&#8220;{}&#8220; sticky_enabled=&#8220;0&#8243;]<\/p>\n<h2>2009 Financial Reports<\/h2>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TDRNQ4FS033109.pdf\" target=\"_blank\" rel=\"noopener\">Yearly results March 2009<\/a><br \/><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TDRNQ4MDA033109.pdf\" target=\"_blank\" rel=\"noopener\">Yearly results March 2009 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/2009-Q3-FS.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 December 2009<\/a><br \/><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/2009-Q3-MDA.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 3 December 2009 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a><\/p>\n<p><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TD-FS-Q1-June-2009.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 Jun 2009<\/a><br \/><a href=\"https:\/\/pasinex.com\/wp-content\/uploads\/2012\/05\/TD-MDA-June-30-2009.pdf\" target=\"_blank\" rel=\"noopener\">Quarter 1 June 2009 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)<\/a><\/p>\n<p>* Per 2013 hat Pasinex das Ende seines Wirtschaftsjahres von M\u00e4rz auf Dezember verlegt. Aus diesem Grund werden im Jahr 2012 drei Quartale dargestellt.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2022 Financial Reports Quarter 3 September 2022 Finanzberichte Quarter 3 September 2022 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A) Quarter 2 June 2022 Finanzberichte Quarter 2 June 2022 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A) Quarter 1 March 2022 Finanzberichte Quarter 1 March 2022 Stellungnahme und Analyse der Unternehmensf\u00fchrung (MD&amp;A)2021 Financial Reports Final Year ended December 2021 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":6364,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-6368","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pasinex.com\/de\/wp-json\/wp\/v2\/pages\/6368","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pasinex.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pasinex.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pasinex.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pasinex.com\/de\/wp-json\/wp\/v2\/comments?post=6368"}],"version-history":[{"count":0,"href":"https:\/\/pasinex.com\/de\/wp-json\/wp\/v2\/pages\/6368\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/pasinex.com\/de\/wp-json\/wp\/v2\/pages\/6364"}],"wp:attachment":[{"href":"https:\/\/pasinex.com\/de\/wp-json\/wp\/v2\/media?parent=6368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}